Rothschild Rates CME buy, $323 Price Target

Rothschild Upgrades CME Group Inc.

Rothschild has raised its rating on CME Group Inc. to "Buy" with a new price target of $323. This upgrade comes as the stock trades at $266.08, reflecting a significant gap between its current price and the new target. The action was reported on June 11, 2026, as CME Group continues to operate in the financial services sector, providing various trading and clearing services.

Analysts Set New Price Targets

Simon Clinch of Rothschild stated the rationale behind the upgrade, suggesting that market conditions and CME’s performance may justify a higher valuation. The new target price indicates potential growth for the company as it aims to meet evolving market demands. Currently, CME Group’s shares are well below the new price target, which suggests an opportunity for investors, depending on future market movements.

Other analysts have also weighed in on CME Group's prospects. For instance, on October 14, 2026, Wells Fargo maintained its "Overweight" rating and raised its price target to $315 from $301. Morgan Stanley also holds an "Overweight" rating with a target of $337. Barclays and UBS have given more cautious assessments with their "Equal-Weight" and "Neutral" ratings, setting targets of $281 and $270, respectively. The average consensus price target among analysts currently stands at $283.60, indicating an overall optimistic outlook despite varied opinions.

Recent Insider Transactions

Insider activity at CME Group has been notable. On June 25, 2026, Timothy Bitsberger purchased 645 shares for $145,125, while Daniel Kaye made a similar purchase of 645 shares for the same value. Other insiders, including Ford Harold Eugene Jr. and Tierney Robert Jr., also bought shares on the same date, with each acquiring 645 shares valued at $145,125. These transactions underscore a belief in the company’s long-term prospects, especially as the stock hovers near its recent lows.

CME Group Stock Overview

Trading at $266.08, CME Group's stock is positioned below its 50-day moving average of $266.98, suggesting it may have room to maneuver in the upcoming months. The stock has experienced a 52-week range from $218.31 to $329.16, highlighting its volatility in the current market environment. Investors will be watching closely to see if the recent upgrades translate into a stronger stock performance.

Company Background

CME Group Inc. operates global markets for trading futures and options on various contracts. The company serves a wide array of clients, including traders and financial institutions, providing essential clearing and data services. As it continues to adapt to market trends, updates from analysts and insider transactions may provide insights into its future direction.

What's Ahead for CME Group Inc.

CME Group's next earnings report is scheduled for October 21, 2026. As with all 13F filings, this rating reflects past positions and may not represent current holdings. Investors will be keen to see how the company's strategies and market developments affect its performance leading up to this date.